BESPONSA
BESPONSA
Approved
DIN Number
02473909
Drug Class
Human
Market Date
May 3, 2018
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02473909
AIG Number0160110001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FB01 INOTUZUMAB OZOGAMICIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
INOTUZUMAB OZOGAMICINActive
Strength: 0.9 MG / VIAL
Monograph: INOTUZUMAB OZOGAMICIN